Keurig Dr Pepper Inc.

source: coverage-next-full ticker: KDP step: 01 title: Business Model & Value Chain retrieved: 2026-05-28

Step 01 — Business Model & Value Chain

Key Findings

• KDP is a brand-IP-led beverage operator with full-stack DSD distribution in North America, generating ~$16.6B FY2025 revenue across three segments (US Refreshment Beverages ~63%, US Coffee ~27%, International ~10%) [S1][S2].
• The economic engine is owned and licensed brand IP (Dr Pepper, Snapple, Canada Dry, 7UP, Mott's, Keurig, GHOST, Bloom) monetized through a proprietary US direct-store-delivery (DSD) network — one of three large US beverage DSD networks alongside Coca-Cola and PepsiCo bottlers [S3]. This DSD network is a structural moat: it converts brand demand into retail availability without intermediary friction.
• Coffee operates a razor + blade model at scale: ~40M Keurig brewers seeded in US homes [S4] generate recurring K-Cup pod revenue. The hardware-pod attach economics resemble a consumables business with installed-base inertia.
• Post-JDE close (April 1, 2026), the entity becomes a global coffee + North American beverages combo with explicit intent to spin into two separately listed companies after integration [S5]. The value-chain map in this step describes the pre-split combined structure.

Implications for Thesis and Valuation

• Revenue durability is grounded in (a) Dr Pepper trademark loyalty (~80+ years), (b) Keurig brewer installed-base lock-in, (c) DSD network breadth. None require ongoing innovation to maintain baseline cash flow.
• Growth comes from three layers: (1) Dr Pepper share gains in US CSDs, (2) energy-drinks expansion via GHOST + Bloom, (3) post-JDE global coffee scale. Each has distinct unit economics that will be modeled separately downstream.
• Valuation must reflect the announced two-company separation: long-term steady-state value is best assessed as Refreshment Beverages Co. (stable mid-single growth, dividend payer) + Global Coffee Co. (mid-single-digit organic growth, lower-margin, more international FX exposure) rather than as a single combined entity.

Objective

Map KDP's business model, value-chain layers, customer economics, and revenue model. Establish the layered structure that Steps 02 (industry), 03 (revenue architecture), and 10 (moat) will refine.

Narrative Analysis

KDP sells branded beverages through retail (grocery, mass, club, c-store, dollar) and foodservice channels in North America, augmented by an at-home single-serve coffee ecosystem and — after April 2026 — a global packaged-coffee footprint via JDE Peet's [S1][S5].

Core revenue model — branded beverages segment. KDP owns or licenses brand IP (~125 brand families), produces concentrate/syrup at internal plants, packages/bottles at company-owned and contract-bottler facilities, and distributes via its proprietary DSD network and warehouse channels. The DSD model lets KDP control shelf placement, refresh frequency, and promotional execution at the store level — a meaningful operating moat in mature retail [S3]. Volume is sold to retailers at wholesale; final consumer purchase is made at retail.

Razor + blade — coffee segment. Keurig brewers (made at low margin, sometimes intentionally subsidized) seed the installed base; K-Cup pod sales (high margin, recurring, ~6-month consumption cycle) generate the durable cash flow. KDP estimates ~40M active brewers in US homes [S4]. Licensed brand partners (Starbucks, Dunkin', etc.) pay for K-Cup format access, providing high-margin license revenue without inventory exposure.

Energy drinks — emerging layer. GHOST (acquired 60% Jan 2025, remaining 40% planned 2028) plus Bloom (partnership) give KDP a position in the fastest-growing US beverage subcategory. Unit economics in energy are attractive (high gross margin, premium price points), and KDP's DSD network is the lever — GHOST struggled with distribution depth pre-acquisition [S6].

International — Mexico-led. Peñafiel is the #2 carbonated mineral water in Mexico; Squirt is a top brand. Canada operations distribute Dr Pepper/Snapple portfolio. Both are mature, GDP-paced markets but offer FX-translation exposure.

Post-JDE addition — global packaged coffee. Jacobs, Douwe Egberts, Peet's Coffee, L'OR, Tassimo, Senseo, Old Town White Coffee — predominantly European and Asian retail and foodservice channels. JDE Peet's was the global #2 packaged coffee company pre-acquisition (behind Nestlé). Brings ~€8B+ revenue, ~22%+ EBITDA margin, and distribution depth in 100+ countries [S5].

Customer economics. End customer (consumer) buys at retail; KDP earns the spread between input/manufacturing/distribution cost and wholesale price to retailer. The "stickiest" customer relationships are (a) Keurig brewer households (hardware lock-in), (b) Dr Pepper habit consumers (trademark loyalty), (c) commercial coffee accounts via JDE in Europe. Retailer relationships are concentrated — Walmart, Kroger, Costco, Target are top US accounts; major grocery chains are top international accounts.

Evidence and Sources

Value-Chain Layer Map

Assumption Register Updates

(No new numeric assumptions in this step; structure-only. Future quantification of brand-level revenue mix will be added in Step 03.)

Tables and Calculations

Segment Revenue Split (FY2025, USD M, approximate)

Segment-level operating margins are approximate from public reconciliation tables; precise breakdown will be cross-checked in Step 03.

Revenue Model Type by Segment

Open Questions and Data Gaps

• Exact brand-level revenue (e.g., Dr Pepper alone vs. Snapple vs. Canada Dry within US RB) is not disclosed; Step 03 will use Circana category share + IR commentary to triangulate
• K-Cup attach rate per brewer (annual pods/brewer) not disclosed in detail; can be estimated from segment volume data
• JDE Peet's standalone P&L only available from JDE's pre-deal disclosures (Euronext filings through April 2026); ongoing breakdown will be at KDP's segment-reporting discretion post-Q2 2026

Next-Step Dependencies

Step 02 will use this value-chain layer map to assess where competitive friction is highest (concentrate mfg, DSD, brand IP) and structure the Porter five-forces analysis accordingly.

Source Index

source: coverage-next-full ticker: KDP step: 12 title: Catalysts / Analyst Debate (Bull vs. Bear) retrieved: 2026-05-28

Step 12 — Catalysts / Analyst Debate

Note: This step adopts the /full-research-gpt Step 12 analyst-debate analytical framework but, since earnings-call transcripts are intentionally not loaded in the coverage-next-full path, the bull/bear positions are reconstructed from sell-side notes, KDP press releases, prepared-remarks summaries embedded in 8-Ks, and consensus aggregators rather than direct CEO/CFO color. This means nuance on forward guidance from management Q&A is not captured here.

Key Findings

• The 12-month KDP investment debate is dominated by three intersecting questions: (1) Does the JDE Peet's integration deliver promised cost + revenue synergies on schedule, (2) Does the planned split into Refreshment Beverages Co. + Global Coffee Co. create sum-of-parts value, and (3) Can Dr Pepper continue gaining US CSD share at 50-100bps annually [S1][S2].
• Sell-side consensus is constructive but cautious: Buy/Outperform = 10, Hold = 7, Sell = 0; average 12-month price target ~$35.47 vs. ~$29.30 spot = ~21% implied upside [S3]. Bulls argue the leverage spike is transitory; bears point to integration risk and the GLP-1 secular drag.
• The biggest near-term catalyst (positive) is the Q3 2026 earnings report — first full quarter of post-JDE consolidated results — which will set the integration credibility baseline.
• The biggest near-term risk (negative) is a guidance trim if synergy capture lags, which would cement the bear thesis.

Implications for Thesis and Valuation

• The base-case 12-month TSR scenario is ~10-15% (upside to ~$33-34 + 3.2% dividend) reflecting modest deleveraging credit and a small split-optionality bump.
• The bull-case 24-month TSR scenario is +40-50% if the split clears antitrust + JDE synergies deliver $300M+ annualized.
• The bear-case 12-month TSR scenario is -15-20% if Q3 2026 disappoints or JDE leverage burdens force dividend signaling concerns.

Objective

Reconstruct the canonical bull/bear analyst debate from filings + consensus + recent news; assess sentiment; identify the next 4-6 catalysts (positive and negative) that will resolve key debate questions; close with a 3+3 Bull Case / Bear Case bullet block that feeds /complete-coverage Step 15 and the public /stocks page.

Narrative Analysis

The Three Active Debates

Debate #1 — JDE Peet's Integration: Value Creation vs. Distraction

The dominant question. Bulls (BofA, Goldman, Jefferies in late-Feb/March 2026 notes) emphasize that KDP gains global coffee scale that closes the gap with Nestlé, that ~$200-400M cost synergies are achievable given overlapping G&A and procurement, and that the deal is structurally accretive to long-term ROIC if the split unlocks separate-multiple value. Bears (UBS, Wells Fargo, Truist) argue the deal is strategically scattershot — KDP is already in coffee via Keurig — and that the timing was opportunistic at JDE's distressed multiple rather than strategic. They cite the rapid leverage spike to 4.5x as a constraint on capital return, the integration execution risk for a company doing two transformational deals in 18 months (GHOST + JDE), and the absence of formal synergy targets at the closing [S4].

The neutral read: the deal is defensible at the price paid (12-13x estimated trailing EBITDA, reasonable for a category #2 with stable margins) but executes on uncertain ground. Final grade requires 2027-2028 results.

Debate #2 — The Split Into Two Companies

KDP's announced intent to separate into Refreshment Beverages Co. (US CSDs + DSD-distributed brands + energy) and Global Coffee Co. (Keurig + JDE Peet's combined) is a sum-of-parts unlock thesis. Bulls model: Refreshment Beverages Co. at 16-18x EBITDA (similar to KO/PEP standalone CSD optionality), Global Coffee Co. at 12-14x EBITDA (Nestlé Health Science + Lavazza comps). Combined SOP = ~$33-37/share, vs. current ~$29-30. Implied upside ~15-25% if split executes by 2028.

Bears point to (a) execution risk — no formal timetable; (b) potential antitrust modifications to the JDE-acquired assets; (c) the dis-synergy of separating shared services, IT, procurement, marketing infrastructure. Wells Fargo's Feb 2026 note estimates ~$150-200M one-time separation costs and ~$50-75M annual dis-synergies post-split [S5].

The neutral read: the option value is real and underpriced, but it is option value — investors must accept multi-year holding and uncertain timing.

Debate #3 — Dr Pepper Share Gain Durability

Dr Pepper has reportedly become the #2 CSD trademark in the US (overtaking Pepsi in some Nielsen/Circana cuts) by mid-2025, with reported share gains of 50-100bps annually since 2022 [S6]. Bulls argue this is structural — the brand has a unique flavor profile, marketing has been highly effective ("Fansville" campaign), and the trade has rewarded Dr Pepper with shelf gains. Bears argue this is mean-reversion-prone — Pepsi has structurally responded with category-management investments and pricing flexibility — and that share gains decelerate once the trademark reaches saturation in heavy-CSD geographies.

The neutral read: continued share gain at 50-100bps annually is achievable through 2026-2027 but the gain rate decelerates as the brand approaches structural ceiling (likely 12-13% US CSD trademark share).

Consensus Snapshot (as of late May 2026)

Catalyst Calendar (next 18 months)

Recent News Flow (last 90 days)

• April 23, 2026: Q1 2026 earnings — reaffirmed FY 2026 guidance of low-DD net sales + adj EPS growth; commentary positive on Dr Pepper share, US Coffee stable, GHOST contributing 6+ pp [S7]
• April 1, 2026: JDE Peet's deal closed — leadership announcements (Rafael Oliveira to lead Global Coffee Co.; Tim Cofer to lead Refreshment Beverages Co.) [S2]
• March 10, 2026: Equity offering completed — 130M shares at $26.50 = $3.45B [S8]
• February 23, 2026: Financing transactions detailed in 8-K — $4.5B convertible preferred (Apollo/KKR), $9B new term debt [S1]
• February 24, 2026: Q4 2025 earnings release — initial FY 2026 guide given; reaffirmed at Q1 2026 [S9]

Sell-Side Sentiment Detail

• Bulls (avg PT ~$38-42): BofA ($42), Goldman ($40), Jefferies ($38), Morgan Stanley ($39). Thesis: JDE creates global coffee #2; split unlocks SOP; Dr Pepper compounds share; energy via GHOST scales; deleveraging credit by end-2027.
• Holds (avg PT ~$32-35): UBS ($32), Wells Fargo ($34), Truist ($33), Citi ($35). Thesis: Deal-execution uncertainty + leverage drag + GLP-1 long-term overhang offset operational momentum.
• No active Sell ratings as of May 2026.

Variant Analyst Views (Worth Highlighting)

• Goldman flags KDP as a "core long-duration compounder" trading at a discount to KO/PEP not justified by 2028 normalized economics [S3].
• UBS flags the convertible preferred as the most under-discussed risk — sponsor dilution at conversion could meaningfully reset share count [S3].
• Wells Fargo estimates ~$150-200M one-time separation costs and ~$50-75M annual dis-synergies on the split [S5].

Assumption Register Updates

• A24: 12-month PT (consensus mean): $35.47 — Type: Fact
• A25: Spread to bull PT: ~$42 = ~43% upside — Type: Fact
• A26: Spread to bear PT: ~$24 = ~18% downside — Type: Fact
• A27: Implied probability-weighted 12mo return (consensus-weighted): ~12-15% — Type: Estimate

Tables and Calculations

Bull / Bear / Neutral Probability Weights (filings + consensus derived)

24-Month Implied Returns by Scenario

The 24-month probability-weighted return is materially above the 12-month consensus PT-implied return (~21%) because the split optionality lengthens the realization horizon.

Open Questions and Data Gaps

• Apollo/KKR convertible preferred conversion price — not in public filings; matters for diluted share count
• Formal synergy quantification — KDP has not publicly committed to a $-target
• Split timeline — explicit Form-10 filing date is the key data point still missing
• Q2 2026 print (late July) is the next material data injection

Next-Step Dependencies

Step 13 (/complete-coverage forecast) builds explicit revenue/margin/EPS forecasts using the assumption register above. Step 15 scenarios formalize the 30/45/25 probability weights. Step 16 (Variant) examines what the market is mispricing vs. consensus.

Source Index

Bull Case — 3 bullets

1. JDE Peet's integration delivers $300M+ run-rate synergies + Refreshment Beverages Co. + Global Coffee Co. split successfully executes by 2028 — sum-of-parts implies ~$33-37/share equity value, ~15-25% upside from current ~$29.30 with the split unlocking previously-discounted coffee economics at coffee-pure-play multiples (Nestlé Health Science / Lavazza comp set).
2. Dr Pepper sustains 50-100bps annual US CSD trademark share gains through 2026-2027 — combined with disciplined pricing (mid-single-digit net realized rev / case via Zero Sugar mix + premiumization), the brand alone could contribute 200-300bps of organic growth, providing a defensible compounder profile even before GHOST/Bloom scaling.
3. GHOST + Bloom scale to $1B+ combined energy revenue by 2028 — KDP's DSD network turns under-distributed cult brands into national distribution; energy/wellness becomes a 10%+ revenue segment with double-digit organic growth, structurally diversifying the portfolio away from CSD GLP-1 risk.

Bear Case — 3 bullets

1. **JDE Peet's integration disappoints — synergies <$150M, split delayed past 2028, or dis-synergies higher than modeled** — leverage stays elevated at >4x net debt/EBITDA through 2027, dividends grow at single-digits not double-digits, and the equity multiple compresses to ~11-12x adj EPS (vs. KO/PEP at ~22-25x).
2. GLP-1 secular demand erosion accelerates beyond mitigation pace — US household penetration of semaglutide/tirzepatide hits 25%+ by 2028 (vs. 12-15% in 2026), driving 1.5-2.0pp annual CSD volume drag that Zero Sugar/Bloom upside can only partially offset; results miss consensus organic growth by 100-200bps annually 2027-2028.
3. Apollo/KKR convertible preferred dilution surprises — sponsors exit at conversion in 2027-2028 adding 7-9% to diluted share count, simultaneously a Mondelez residual stake sell-down pressures price; combined cap-structure overhang produces a 12-month price drag of 10-15% even before fundamental concerns crystallize.